Contents | Journals

Annual Index

Index to Volume 4, Numbers 1-6.
The index to Volume 4 is comprised of two parts: an author index and a subject index.
IssuePages
January/February1-96
March/April97-236
May/June237-358
July/August359-446
September/October447-538
November/December539-640
AUTHOR INDEX

Anderson, Robert J., et al. The Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies. 1998; 4: 422. Descriptive Report.

Badger, Bruce. see Grier, Dana, et al. 1998; 4: 478. Campus.

Bailey, Michael, et al. Innovative Drug Formulary Management Through Computer-Assisted Protocols. 1998; 4: 246. Feature.

Bair, Teri L. see Ginsburg, Diane B., et al. 1998; 4: 193. Caveats.

Baran, Robert W. Room in Brooklyn; Edward Hopper. 1998; 4: 1. Cover Impressions.

Barisano, Anthony, et al. Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. 1998; 4: 599. Comparative Research.

Barrington, Monica. Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. 1998; 4: 73. Comparative Research.

Bataoel, James R. Pharmacy Internship Offers Real-World Exposure to Managed Care Pharmacy Practice. 1998; 4: 605. Campus.

Beardsley, Bob, et al. Counseling: Where Does the Profession Stand? 1998; 4: 78. Caveats.

Bjornson, Darrel C. see Phillips, Charles R., et al. 1998; 4: 183. Comparative Research.

Bloom, Marlene Z. Connecting Physicians to Pharmacies-and Patients. 1998; 4: 473. Spotlight.

Bloom, Marlene Z. Mississippi Medicaid Waiver Breaks New Ground for Pharmacists. 1998; 4: 564. Spotlight.

Boland, Beth. The Evolution of Best-in-Class Pharmacy Management Techniques. 1998; 4: 366. Feature.

Bramlet, Dean A., et al. A Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. 1998; 4: 483. Comparative Research.

Breault, Diane. Health Care Communications Agencies Respond to Managed Care. 1998; 4: 9. Feature.

Brixner, Diana. see Wilson, Marcus, et al. 1998; 4: 194. Descriptive Report.

Brunner, Lane J. The NTI Debate. 1998; 4: 289. Caveats.

Carter, Barry L. see Grier, Dana, et al. 1998; 4: 478. Campus.

Chan, Julia. see Ettinger, Bruce, et al. 1998; 4: 488. Comparative Research.

Chevalier, Kimiko. see Salmon, J. Warren, et al. 1998; 4: 123. International.

Chevalier, Kimiko, et al. International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. 1998; 4: 567. International.

Clark, David C. , Medicare and Managed Care: Emerging Partnerships. 1998; 4: 105. Feature.

Connolly, Nancy. see Ettinger, Bruce, et al. 1998; 4: 488. Comparative Research.

Craig, Robert P. The Patient as a Partner in Prescribing: Direct-to-Consumer Advertising. 1998; 4: 15. Feature.

Crawley, Joseph A. see Keyser, Mary S., et al. 1998; 4: 64. Comparative Research.

Crawley, Joseph A. see Keyser, Mary S., et al. 1998; 4: 336. Comparative Research.

Crischilles, Elizabeth A. see Phillips, Charles R., et al. 1998; 4: 183. Comparative Research.

Dedhiya, Seema D. see Salmon, J. Warren, et al. 1998; 4: 23. Feature.

Desselle, Shane, et al. The Evolution of Pharmaceutical Care into Managed Care Environments. 1998; 4: 55. Continuing Education.

Desselle, Shane, et al. The Evolution of Pharmaceutical Care into Managed Care Environments. (Desselle, Shane, et al.) 1998; 4: 61. CE Exam.

Desselle, Shane, et al. The Importance of Communication Skills for the Managed Care Pharmacist. 1998; 4: 102. Perspectives.

Dickson, W. Michael. see Kozma, Chris M., et al. 1998; 4: 205. Comparative Research.

Dole, Ernest J. see Gupchup, Gireesh V., et al. 1998; 4: 495. Comparative Research.

Edgell, Eric T. see Summers, Kent H., et al. 1998; 4: 42. Review.

Eicher, Jessica. see Wilson, Marcus, et al. 1998; 4: 194. Descriptive Report.

Ettinger, Bruce, et al. Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. 1998; 4: 488. Comparative Research.

Fallik, Bruce B. Integration: The Future of Pharmacy. 1998; 4: 452. Perspectives.

Felkey, Bill G., et al. Technology and Automation Update. 1998; 4: 345. Continuing Education.

Ferro, Karen. see Bailey, Michael, et al. 1998; 4: 246. Feature.

Forsstrom, Kristi. see Anderson, Robert J., et al. 1998; 4: 422. Descriptive Report.

Gericke, Kristin R., et al. Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. 1998; 4: 407.

Ginsburg, Diane B. see Beardsley, Bob et al. 1998; 4: 78. Caveats.

Ginsburg, Diane B. Pharmacy: Over- or Under-Regulated? 1998; 4: 193. Caveats.

Goldberg, George A. see Keyser, Mary S., et al. 1998; 4: 64. Comparative Research.

Goldberg, George A. see Keyser, Mary S., et al. 1998; 4: 336. Comparative Research.

Graden, Suzanne E., et al. Performance Reporting for Managed Care Prescription Programs. 1998; 4: 160. Continuing Education.

Graden, Suzanne E., et al. Performance Reporting for Managed Care Prescription Programs. 1998; 4: 171. CE Exam.

Grapes, Z. Tom. Expanding Pharmacy Students' Understanding of Managed Care. 1998; 4: 223. Campus.

Grier, Dana, et al. The University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership. 1998; 4: 478. Campus.

Gupchup, Gireesh V., et al. Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. 1998; 4: 495. Comparative Research.

Hamilton, William R., et al. A Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. 1998; 4: 174. Comparative Research.

Hargis, Jo Ellen. Biotechnology as a Pharmacy Specialty. 1998; 4: 465. Feature.

Hauser, Robert. Patient Protection: Will Pharmacoeconomics Complement or Conflict? 1998; 4: 381. Caveats.

Hedayati, Samuel, et al. A Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. 1998; 4: 584. Comparative Research.

Hessen, Jody. Oncology Drugs and Managed Care. 1998; 4: 374. Feature.

Hetler, Tamara A. see Hamilton, William R., et al. 1998; 4: 174. Comparative Research.

Holubiak, Myron. Local Area Market Dynamics. 1998; 4: 115. Feature.

Hopkins, Ursula K. see Hamilton, William R., et al. 1998; 4: 174. Comparative Research.

Hsiao, L. Daphne. see Bramlet, Dean A., et al. 1998; 4: 483. Comparative Research.

Hunter, Tracy S., see Desselle, Shane, et al. 1998; 4: 55. Continuing Education.

Hurd, Peter D. see Shalita, Eric A., et al. 1998; 4: 413. Comparative Research.

Hurd, Peter D. see Schafermeyer, Kenneth W. 1998; 4: 504. Continuing Education.

Hurd, Peter D. Research Methodology: Some Statistical Considerations. 1998; 4: 617. Continuing Education.

Hylan, Timothy R. see Summers, Kent H., et al. 1998; 4: 42. Review.

James, John D. see Shalita, Eric A., et al. 1998; 4: 413. Comparative Research.

Kaldy, Joanne. Writers are More Welcome than Ever. 1998; 4: 6. Perspectives.

Kaldy, Joanne. Flowers and Birds; Sesshu Toyo. 1998; 4: 97. Cover Impressions.

Kaldy, Joanne. Kindred Spirits; Asher B. Durand. 1998; 4: 237. Cover Impressions.

Kaldy, Joanne. Springtime; Claude Monet. 1998; 4: 359. Cover Impressions.

Kaldy, Joanne. Several Circles; Wassily Kandinsky. 1998; 4: 447. Cover Impressions.

Kaldy, Joanne. The Skater; Gilbert Stuart. 1998; 4: 539. Cover Impressions.

Kalmanowicz, Jeffrey. see Wilson, Marcus, et al. 1998; 4: 194. Descriptive Report.

Kaul, Alan F. see Bramlet, Dean A., et al. 1998; 4: 483. Comparative Research.

Keating, Edward J. Maximizing Generic Substitution in Managed Care. 1998; 4: 557. Feature.

Kenreigh, Charlotte A., et al. The Survey Syndrome. 1998; 4: 544. Caveats.

Keyser, Mary S., et al. Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. 1998; 4: 64. Comparative Research.

Keyser, Mary S., et al. Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. 1998; 4: 336. Comparative Research.

Kleinstiver, Peter W. see Hedayati, Samuel, et al. 1998; 4: 584. Comparative Research.

Kozma, Chris M., et al. Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. 1998; 4: 205. Comparative Research.

Kramer, Jeffrey A. see Barisano, Anthony, et al. 1998; 4: 599. Comparative Research.

Kucukarslan, Suzan N., et al. Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. 1998; 4: 311. Comparative Research.

Lai, L. Leanne, et al. Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. 1998; 4: 303. Comparative Research.

Langley, Paul. The Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? 1998; 4: 593. Comparative Research.

Larson, Lon L. see Phillips, Charles R., et al. 1998; 4: 183. Comparative Research.

Lin, Swu-Jane. see Salmon, J. Warren, et al. 1998; 4: 80. Campus.

Lin, Swu-Jane. Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. 1998; 4: 275. International.

Lively, Buford T. see Gupchup, Gireesh V., et al. 1998; 4: 495. Comparative Research.

Louie, Clifton. see Gericke, Kristin R., et al. 1998; 4: 407. Comparative Research.

MacKinnon III, George E. Cooperative Learning in a Required Outcomes Assessment Course. 1998; 4: 432. Campus.

Malone, Daniel. see Grier, Dana, et al. 1998; 4: 478. Campus.

McPeak, Mary Ellen. State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. 1998; 4: 546.

Minor, Paul A., et al. If It Is Worth Doing, It Is Worth Doing Well…Then Proven. 1998; 4: 359. Caveats.

Motheral, Brenda R. Research Methodology: Hypotheses, Measurement, Reliability, and Validity. 1998; 4: 382. Continuing Education.

Mullenix, Timothy A. see Kozma, Chris M., et al. 1998; 4: 205. Comparative Research.

Nee, Chris. Academic Detailing and HMG CoA Agents. 1998; 4: 94. Feedback.

Parker, Dianne A. Kane. Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. 1998; 4: 257. Feature.

Pathak, Dev S. see Kucukarslan, Suzan N., et al. 1998; 4: 311. Comparative Research.

Patwell, John. see Wilson, Marcus, et al. 1998; 4: 194. Descriptive Report.

Pedersen, Craig A. Managed Care Pharmacy at Creighton University. 1998; 4: 324. Campus.

Phillips, Charles R., et al. The Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review. 1998; 4: 183. Comparative Research.

Poikonen, John. see Felkey, Bill G., et al. 1998; 4: 345. Continuing Education.

Pressman, Alice. see Ettinger, Bruce, et al. 1998; 4: 488. Comparative Research.

Reeder, C.E. see Kozma, Chris M., et al. 1998; 4: 205. Comparative Research.

Richards, Warren. Pharmacy: Looking Back to See the Future. 1998; 4: 454. Feature.

Salmon, J. Warren, et al. First Managed Care Pharmacy Course at the University of Illinois at Chicago. 1998; 4: 80. Campus.

Salmon, J. Warren, et al. The Vital Role of Pharmacy Benefit Management Firms in Health Services Research. 1998; 4: 23. Feature.

Salmon, J. Warren, et al. International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. 1998; 4: 123. International.

Salmon, J. Warren. see Chevalier, Kimiko, et al. 1998; 4: 567. International.

Sardinha, Carol. Electronic Prescribing: The Next Revolution in Pharmacy? 1998; 4: 35. Spotlight.

Schafermeyer, Kenneth W. see Graden, Suzanne E., et al. 1998; 4: 160. Continuing Education.

Schafermeyer, Kenneth W., et al. Research Methodology: Designing a Research Study. 1998; 4: 504. Continuing Education.

Schein, Jeffrey. see Ettinger, Bruce, et al. 1998; 4: 488. Comparative Research.

Schwartz, Arnold and Marie. see Desselle, Shane, et al. 1998; 4: 102. Perspectives.

Shalita, Eric A., et al. Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. 1998; 4: 413. Comparative Research.

Shaw, Michele M. see Keyser, Mary S., et al. 1998; 4: 64. Comparative Research.

Shaw, Michele M. see Keyser, Mary S., et al. 1998; 4: 336. Comparative Research.

Shoheiber, Omar. see Wilson, Marcus, et al. 4: 194. Descriptive Report.

Silver, Paula. see Ettinger, Bruce, et al. 1998; 4: 488. Comparative Research.

Singhal, Puneet K. see Gupchup, Gireesh V., et al. 1998; 4: 495. Comparative Research.

Sorkin, Alan A. see Lai, L. Leanne, et al. 1998; 4: 303. Comparative Research.

Sorofman, Bernard A. see Phillips, Charles R., et al. 1998; 4: 183. Comparative Research.

Strand, Linda M. Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. 1998; 4: 242. Perspectives.

Stoukides, Cheryl A. see Bramlet, Dean A., et al. 1998; 4: 483. Comparative Research.

Summers, Kent H., et al. The Use of Economic Models in Managed Care Pharmacy Decisions. 1998; 4: 42. Review.

Summers, Kent. see Kucukarslan, Suzan N., et al. 1998; 4: 311. Comparative Research.

Tullio, Carl J. see Shalita, Eric A., et al. 1998; 4: 413. Comparative Research.

Wanke, Lee A. Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. 1998; 4: 364. Perspectives.

Wagner, Linda Timm. see Kenreigh, Charlotte A., et al. 1998; 4: 544. Caveats.

Weber, Mary P. A Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. 1998; 4: 293. Comparative Research.

White, Jennifer. see Minor, Paul A., et al. 1998; 4: 359. Caveats.

Wilson, Marcus, et al. The Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting. 1998; 4: 194. Descriptive Report.

Wuller, Cynthia A. see Shalita, Eric A., et al. 1998; 4: 413. Comparative Research.

Zimmerman, Allan. Successful Disease Management Programs For Health And Welfare Fund Union Groups. 1998; 4: 268. Feature.

SUBJECT INDEX

ACE inhibitor
The Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting. (Wilson, Marcus, et al.) 1998; 4: 194.

ACG case-mix adjustment
Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.

ALS, see Amyotrophic lateral sclerosis

AMCP conventions

  • AMCP Board Approves Annual Exhibit Program. 1998; 4: 607.
  • AMCP's 10th Annual Meeting Preliminary Program. 1998; 4: 139.
  • AMCP's 1998 Educational Conference Preliminary Program. 1998; 4: 395.

    AMCP Reports
    Managed Care Pharmacy Residency Programs. 1998; 4: 518.

    AMCProgress

  • AMCP Approves Drafting of Guidelines for Formulary Submissions. 1998; 4: 607.
  • AMCP Approves Position Statement on Patient Confidentiality. 1998; 4: 534.
  • AMCP Board Approves Annual Exhibit Program. 1998; 4: 607.
  • AMCP Cooperates on Automation White Paper. 1998; 4: 607.
  • AMCP Issues Position Statement on Therapeutic Interchange. 1998; 4: 87.
  • AMCP Joins "SCRIPT" Coalition to Investigate Medication Problems. 1998; 4: 607.
  • AMCP Office Move Complete. 1998; 4: 353.
  • AMCP Opposes FDA Draft Guidance on Health Promotion. 1998; 4: 436.
  • AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.
  • AMCP to Collaborate with CDC. 1998; 4: 226.
  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.
  • Academy Decries Proposal to End Need for Pharmacists. 1998; 4: 534.
  • Board Approves Supplements to JMCP. 1998; 4: 226.
  • Eliminating Pharmacists for Medicare/Medicaid? 1998; 4: 353.
  • HCFA Proposes Standards for Electronic Transmission. 1998; 4: 436.
  • New Brochure Highlights Disease State Management. 1998; 4: 226.
  • Two New Residency Activities Approved. 1998; 4: 226.

    Abstracts, Articles

  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.
  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.
  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • A Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.A Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.
  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.
  • A Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.
  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.
  • Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.
  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.
  • A Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Abstracts, poster sessions

  • Comparison of SF-12 and SF-36 as Generic Health-Related Quality-of-Life Measures in Patients with Osteoarthritis. 1998; 4: 527.
  • Comprehensive Review of Managed Care Formularies in the United States. 1998; 4: 528.
  • CYP3A4: Undetermined Impact on 1.1 Million Health Plan Members in Minnesota. 1998; 4: 531.
  • Dihydropyridine Conversion: Was it a Good Decision? 1998; 4: 527.
  • Effect of a Closed Formulary on Pharmaceutical Utilization, Expenditures, and Treatment Continuation, The. 1998; 4: 528.
  • Patterns and Costs of Pharmaceutical Care Among Newly Treated Gastroesophageal Reflux Disease (GERD Patients: H2 Blockers Compared to Proton Pump Inhibitors. 1998; 4: 531.Quality Improvement Initiatives in a Managed Care Pharmacy Residency Program. 1998; 4: 527.
  • Reasons Given for Discontinuing Antihypertensive Medications. 1998; 4: 530.
  • Research Experience and Interests of Managed Care Organizations. 1998; 4: 530.
  • Validation of a Primary Open-angle Glaucoma Costing Model: Second-line Latanoprost vs. Dorzolamide vs. Brimonidine, Monotherapy, and in Combination with Beta-adrenergic Blockers. 1998; 4: 530.
  • Unmet Needs in Managed Care for Six Prominent Diseases. 1998; 4: 528.

    Academic publishing
    Writers Are More Welcome Than Ever. (Kaldy, Joanne.) 1998; 4: 6.

    Academy of Managed Care Pharmacy

  • AMCP Approves Drafting of Guidelines for Formulary Submissions. 1998; 4: 607.
  • AMCP Approves Position Statement on Patient Confidentiality. 1998; 4: 534.
  • AMCP Board Approves Annual Exhibit Program. 1998; 4: 607.
  • AMCP Cooperates on Automation White Paper. 1998; 4: 607.AMCP Issues Position Statement on Therapeutic Interchange. 1998; 4: 87.
  • AMCP Joins "SCRIPT" Coalition to Investigate Medication Problems. 1998; 4: 607.
  • AMCP Management Development Program. 1998; 4: 308, 371.
  • AMCP Office Move Complete. 1998; 4: 353.
  • AMCP Opposes FDA Draft Guidance on Health Promotion. 1998; 4: 436.
  • AMCP to Collaborate with CDC. 1998; 4: 226.
  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.
  • AMCP's 10th Annual Meeting Preliminary Program. 1998; 4: 139.
  • AMCP's 1998 Educational Conference Preliminary Program. 1998; 4: 395.
  • Academy Decries Proposal to End Need for Pharmacists. 1998; 4: 534.
  • Board Approves Supplements to JMCP. 1998; 4: 226.
  • Connecting Physicians to Pharmacies-and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Eliminating Pharmacists for Medicare/Medicaid? 1998; 4: 353.
  • Expanding Pharmacy Students' Understanding of Managed Care. (Grapes, Z. Tom.) 1998; 4: 223.
  • HCFA Proposes Standards for ElectronicTransmission. 1998; 4: 436.
  • Managed Care Pharmacy Residency Programs. 1998; 4: 518.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacists. (Bloom, Marlene Z.) 1998; 4: 564.
  • New Brochure Highlights Disease State Management. 1998; 4: 226.
  • Pharmacy Internship Offers Real-World Exposure to Managed Care Pharmacy Practice. (Bataoel, James R.) 1998; 4: 605.
  • Two New Residency Activities Approved. 1998; 4: 226.

    Accreditation
    The Survey Syndrome. (Kenreigh, Charlotte A., et al.) 1998; 4: 544.

    Adjudication
    The Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review. (Phillips, Charles R., et al.) 1998; 4: 183.

    Adverse drug events

  • Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. (Wanke, Lee A.) 1998; 4: 364.
  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Advertising

  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.

    Alendronate
    Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.

    Amyotrophic lateral sclerosis
    Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Anorexiants

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Anticoagulation clinic
    Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.

    Antineoplastics

  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Appetite suppressants
    Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.

    Argus Health Systems Inc.
    Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.

    Asthma
    Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Automation

  • AMCP Cooperates on Automation White Paper. 1998; 4: 607.
  • Connecting Physicians to Pharmacies-and Patients. (Bloom, Marlene Z.) 1998; 4: 473. Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Barriers

  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Biotechnology

  • Biotechnology as a Pharmacy Specialty. (Hargis, Jo Ellen.) 1998; 4: 465.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Bisphosphonates
    Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.

    Blue Cross Blue Shield
    Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.

    Burnout
    Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.

    CDC, see Centers for Disease Control

    CE Exam

  • Evolution of Pharmaceutical Care into Managed Care Environments, The. 1998; 4: 61.
  • Performance Reporting for Managed Care Prescription Programs. 1998; 4: 171.
  • Research Methodology: Designing a Research Study. 1998; 4: 515.
  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. 1998; 4: 389.
  • Research Methodology: Some Statistical Considerations. 1998; 4: 622.
  • Technology and Automation Update. 1998; 4: 351.

    Calcium antagonist
    Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.

    Calcium channel blockers
    Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.

    Campus

  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • Expanding Pharmacy Students' Understanding of Managed Care. (Grapes, Z. Tom.) 1998; 4: 223.
  • First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • Pharmacy Internship Offers Real-World Exposure to Managed Care Pharmacy Practice. (Bataoel, James R.) 1998; 4: 605.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Cancer

  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Case management

  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Caveats

  • Counseling: Where Does The Profession Stand? (Beardsley, Bob, et al.) 1998; 4: 78.
  • If It Is Worth Doing, It Is Worth Doing Well . . . Then Proven. (Minor, Paul A., et al.) 1998; 4: 359.
  • NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289. Pharmacy: Over- or Under-Regulated? (Ginsburg, Diane B., et al.) 1998; 4: 193.
  • Patient Protection: Will Pharmacoeconomics Complement or Conflict? (Hauser, Robert.) 1998; 4: 381.
  • Survey Syndrome, The. (Kenreigh, Charlotte A., et al.) 1998; 4: 544.

    Centers for Disease Control
    AMCP to Collaborate with CDC. 1998; 4: 226.

    Cholesterol management

  • Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Chugai Pharmaceutical Co., Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Colleges of pharmacy

  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Communications

  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Importance of Communication Skills for the Managed Care Pharmacist, The. (Desselle, Shane.) 1998; 4: 102.

    Comparative Research

  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.
  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.
  • Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.
  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.
  • Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Congestive heart failure
    Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.

    Consumers

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.

    Continuing Education

  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.
  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.
  • Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Cooperative learning
    Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.

    Coronary heart disease
    Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.

    Cost benefit analysis
    Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.

    Cost effectiveness

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.

    Costs

  • Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.
  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. (Strand, Linda M.) 1998; 4: 242.
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Cover Impressions

  • Flowers and Birds. (Kaldy, Joanne.) 1998; 4: 97.
  • Kindred Spirits. (Kaldy, Joanne.) 1998; 4: 237.
  • Room in Brooklyn. (Baran, Robert W.) 1998; 4: 1.
  • Several Circles. (Kaldy, Joanne.) 1998; 4: 447.
  • The Skater. (Kaldy, Joanne.) 1998; 4: 539.
  • Springtime. (Kaldy, Joanne.) 1998; 4: 359.

    Credentialing
    If It Is Worth Doing, It Is Worth Doing Well...Then Proven. (Minor, Paul A., et al.) 1998; 4: 359.

    Curriculum

  • AMCP's 1998 Educational Conference. 1998; 4: 395.
  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • Expanding Pharmacy Students’ Understanding of Managed Care. (Grapes, Z. Tom.) 1998; 4: 223.
  • First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Daiichi Pharmaceutical Co., Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Data collection
    Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Decision making

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.
  • Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. (Strand, Linda M.) 1998; 4: 242.
  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Decision tables
    Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.

    Decision trees
    Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.

    Descriptive Reports

  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Detailing, academic
    Academic Detailing and HMG CoA Agents. (Nee, Chris.) 1998; 4: 94.

    Dexfenfluramine

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Diabetes
    Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Disease state management

  • Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.
  • Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • New Brochure Highlights Disease State Management. 1998; 4: 226.
  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.
  • Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Documentation

  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Drug misadventuring
    The Vital Role of Pharmacy Benefit Management Firms in Health Services Research. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Drug safety

  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Drugs, biotech
    Biotechnology as a Pharmacy Specialty. (Hargis, Jo Ellen.) 1998; 4: 465.

    Drug therapy/use

  • AMCP Joins "SCRIPT" Coalition to Investigate Medication Problems. 1998; 4: 607.
  • Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. (Wanke, Lee A.) 1998; 4: 364.
  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.
  • Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. (Strand, Linda M.) 1998; 4: 242.
  • NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289.
  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.

    Drug utilization review

  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Dyspepsia
    Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.

    Economic models

  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Economics

  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.

    Education

  • AMCP Board Approves Annual Exhibit Program. 1998; 4: 607.
  • AMCP Management Development Program. 1998; 4: 308, 371.
  • AMCP's 1998 Educational Conference. 1998; 4: 158, 178, 326, 395, 521.
  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Expanding Pharmacy Students' Understanding of Managed Care. (Grapes, Z. Tom.) 1998; 4: 223.
  • First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • Managed Care Pharmacy Residency Programs. 1998; 4: 518.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Pharmacy Internship Offers Real-World Exposure to Managed Care Pharmacy Practice. (Bataoel, James R.) 1998; 4: 605.
  • Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.
  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.
  • Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.
  • Two New Residency Activities Approved. 1998; 4: 226.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Electronic communication

  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Connecting Physicians to Pharmaciesóand Patients. 1998; 4: 473.
  • HCFA Proposes Standards for Electronic Transmission. 1998; 4: 436.
  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Electronic prescribing

  • Connecting Physicians to Pharmacies-and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    FDA, see Food and Drug Administration

    FTC, see Federal Trade Commission

    Features

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Biotechnology as a Pharmacy Specialty. (Hargis, Jo Ellen.) 1998; 4: 465.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.
  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.
  • Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Federal Trade Commission

  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.

    Feedback
    Academic Detailing and HMG CoA Agents. (Nee, Chris.) 1998; 4: 94.

    Fee-for-service
    Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.

    Fenfluramine

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Fluoxetine

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Food and Drug Administration

  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.
  • Food and Drug Administration draft guidance
  • AMCP Opposes FDA Draft Guidance on Health Promotion. 1998; 4: 436.
  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.

    Foreign competition
    International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.

    Formulary

  • AMCP Approves Drafting of Guidelines for Formulary Submissions. 1998; 4: 607.
  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Fosamax

  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Foundation of Managed Care Pharmacy First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80. Campus.

    Funding, capitated
    Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.

    Fujisawa Pharmaceutical Co., Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Future

  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Integration: The Future of Pharmacy. (Fallik, Bruce B.) 1998; 4: 452.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.

    Gastritis
    Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.

    Gastroesophageal Reflux Disease

  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.

    General practitioner
    Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.

    Generic drugs

  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289. GERD, see Gastroesophageal Reflux Disease

    Guidelines

  • AMCP Approves Drafting of Guidelines for Formulary Submissions. 1998; 4: 607.
  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.
  • Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. (Wanke, Lee A.) 1998; 4: 364.

    HCFA, see Health Care Financing Administration

    HEDIS, see Health Plans and Employment Data Information Set

    Health Alliance Plan

  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Pharmacy Internship Offers Real-World Exposure to Managed Care Pharmacy Practice. (Bataoel, James R.) 1998; 4: 605.

    Health and welfare fund union groups
    Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.

    Health care
    Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.

    Health care market

  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.

    Health Care Financing Administration
    Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.

    Health care, private
    Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.

    Health care reform
    Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.

    Health care research
    Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Health Plan of the Redwoods
    Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.

    Health Plans and Employment Data Information Set

  • AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Health policy, foreign

  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Helicobacter pylori
    Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.

    HMG CoA
    Academic Detailing and HMG CoA Agents. (Nee, Chris.) 1998; 4: 94.

    Hypercholesterolemia
    Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.

    Hypertension

  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Hypotheses

  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.
  • Independent practice associations; Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.

    Informatics

  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Infusion therapy

  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.

    Inodilator infusion therapy

  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.
  • Integrated health care delivery systems; Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.

    International

  • Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.
  • Focus on International. 1998; 4: 88.
  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Japan

  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Law

  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Pharmacy: Over- or Under-Regulated? (Ginsburg, Diane B., et al.) 1998; 4: 193.

    Legislation
    NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289.

    MCOs, see Managed Care Organizations

    Managed care

  • Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care Setting, The. (Wilson, Marcus, et al.) 1998; 4: 194.
  • Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.
  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80. Campus.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Charges by Place and Type of Service. (Keyser, Mary S., et al.) 1998; 4: 336.
  • Gastroesophageal Reflux Disease in a Managed Care Setting: Professional, Facility, and Pharmacy Charges. (Keyser, Mary S., et al.) 1998; 4: 64.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Managed care organizations

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.

    Marketing

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.

    Markov models
    Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Maslach Burnout Inventory
    Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.

    Media
    Media. 1998; 4: 85, 228

    Medial treatment facilities
    Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.

    Medicaid

  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.
  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population–From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Eliminating Pharmacists for Medicare/Medicaid? 1998; 4: 353.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • If It Is Worth Doing, It Is Worth Doing Well… Then Proven. (Minor, Paul A., et al.) 1998; 4: 359.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Medicare

  • Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.
  • Eliminating Pharmacists for Medicare/Medicaid? 1998; 4: 353.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.

    Military
    Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.

    Milrinone

  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.
  • NCPDP, see National Council for Prescription Drug Programs

    Narrow therapeutic index


    NTI Debate, The. (Brunner, Lane J.) 1998; 4: 289.

    National Association of Boards of Pharmacy

  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • National Council for Prescription Drug Programs; Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • National Health Service of Great Britain; Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.

    National Prescription Administrators
    Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.

    Neoplasm
    Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Obesity

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.
  • Omnibus Budget Reconciliation Act
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Oncology

  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Order entry
    Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Orlistat
    Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Osteoporosis
    Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.

    Outcomes

  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Outcomes research

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    P&T, see Pharmacy & Therapeutic Committees

    PCS Health Systems
    University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Partnerships

  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Patient care

  • AMCP Joins "SCRIPT" Coalition to Investigate Medication Problems. 1998; 4: 607.
  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • Patient Protection: Will Pharmacoeconomics Complement or Conflict? (Hauser, Robert.) 1998; 4: 381.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Patient compliance

  • Alendronate Use Among 812 Women: Prevalence of Gastrointestinal Complaints, Noncompliance with Patient Instructions, and Discontinuation. (Ettinger, Bruce, et al.) 1998; 4: 488.
  • Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Patient confidentiality
    AMCP Approves Position Statement on Patient Confidentiality. 1998; 4: 534.

    Patient satisfaction
    Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.

    Peptic ulcer
    Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.

    Performance

  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Perspectives

  • Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. (Wanke, Lee A.) 1998; 4: 364.
  • Importance of Communication Skills for the Managed Care Pharmacist, The. (Desselle, Shane.) 1998; 4: 102.
  • Integration: The Future of Pharmacy. (Fallik, Bruce B.) 1998; 4: 452.
  • Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. (Strand, Linda M.) 1998; 4: 242.
  • Writers Are More Welcome Than Ever. (Kaldy, Joanne.) 1998; 4: 6.

    Pharmaceutical care

  • AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.
  • Academy Decries Proposal to End Need for Pharmacists. 1998; 4: 534.
  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Managing Drug Therapy Decisions: Pay Me Now or Pay Me Later. (Strand, Linda M.) 1998; 4: 242.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Pharmaceutical firms, foreign
    International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.

    Pharmaceutical manufacturers

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Pharmacist counseling

  • Counseling: Where Does The Profession Stand? (Beardsley, Bob, et al.) 1998; 4: 78.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.

    Pharmacist intervention

  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.
  • Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    Pharmacist roles

  • Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Pharmacoeconomics

  • AMCP Approves Drafting of Guidelines for Formulary Submissions. 1998; 4: 607.
  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Cooperative Learning in a Required Outcomes Assessment Course. (MacKinnon III, George E.) 1998; 4: 432.
  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Patient Protection: Will Pharmacoeconomics Complement or Conflict? (Hauser, Robert.) 1998; 4: 381.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Pharmacology

  • Oncology Drugs and Managed Care. (Hessen, Jody.) 1998; 4: 374.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Pharmacy

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Biotechnology as a Pharmacy Specialty. (Hargis, Jo Ellen.) 1998; 4: 465.
  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Eliminating Pharmacists for Medicare/Medicaid? 1998; 4: 353.
  • Integration: The Future of Pharmacy. (Fallik, Bruce B.) 1998; 4: 452.
  • Managed Care Pharmacy at Creighton University. (Pederson, Craig A.) 1998; 4: 324.
  • Medicare and Managed Care: Emerging Partnerships. (Clark, David C.) 1998; 4: 105.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.
  • Pharmacy: Over- or Under-Regulated? (Ginsburg, Diane B., et al.) 1998; 4: 193.
  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.

    Pharmacy administration
    First Managed Care Pharmacy Course at the University of Illinois at Chicago. (Salmon, J. Warren, et al.) 1998; 4: 80.

    Pharmacy and therapeutic committees

  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Pharmacy benefit management

  • AMCP Voices Concern Over Proposed Federal Rules. 1998; 4: 353.
  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Formulary Management by an On-Site School of Pharmacy Faculty Member in a Medicaid Managed Care Organization. (Gericke, Kristin R., et al.) 1998; 4: 407.
  • Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.
  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.
  • Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.
  • University of Colorado School of Pharmacy and the University of Colorado Health Plan Forge a PBM Partnership, The. (Grier, Dana, et al.) 1998; 4: 478.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Pharmacy performance

  • AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Pharmacy regulation

  • Pharmacy: Over- or Under-Regulated? (Ginsburg, Diane B., et al.) 1998; 4: 193.

    Pharmacy reimbursement

  • If It Is Worth Doing, It Is Worth Doing Well… Then Proven. (Minor, Paul A., et al.) 1998; 4: 359.
  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.
  • State-by-State Look at Medicaid Retail Pharmacy Delivery: Trials & Triumphs. (McPeak, Mary Ellen.) 1998; 4: 546.

    Phentermine

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Physicians

  • Connecting Physicians to Pharmacies-and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Physician Attitudes Toward Pharmacist-Run Anticoagulation Clinics in Department of Defense Health Services Region 5. (Shalita, Eric A., et al.) 1998; 4: 413.

    Physician prescribing patterns
    Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.

    Physician report cards
    Evolution of Best-in-Class Pharmacy Management Techniques, The. (Boland, Beth.) 1998; 4: 366.

    Pipeline
    Pipeline. 1998; 4: 82, 179, 321, 420.

    Policy
    International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.

    Practice standards, guidelines

  • Advancing Outcomes Research in Managed Care Pharmacy: A Call to Action. (Parker, Dianne A. Kane.) 1998; 4: 257.
  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Prescribing

  • Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.
  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Health Care Communications Agencies Respond to Managed Care. (Breault, Diane.) 1998; 4: 9.
  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.
  • Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.

    Prescription claims

  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.
  • Pharmacist's Assessment of Second Generation On-Line Prospective Drug Utilization Review, The. (Phillips, Charles R., et al.) 1998; 4: 183.
  • Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    Prescription reminder systems
    Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    Prescription transmittal
    Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    President's Task Force on National Health Care Reform
    Pharmacy: Looking Back to See the Future. (Richards, Warren.) 1998; 4: 454.

    Priority Health
    Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.

    Profiling

  • Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Prozac
    Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Public health
    AMCP to Collaborate with CDC. 1998; 4: 226.

    Qualitative data
    Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.

    Quality of care
    AMCP Publishes Catalog of Quality Pharmacy Indicators. 1998; 4: 87.

    Quality of life

  • Changing Practices in Home Inodilator Infusion Therapy for Advanced Congestive Heart Failure. (Barrington, Monica.) 1998; 4: 73.
  • Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Regulation

  • Academy Decries Proposal to End Need for Pharmacists. 1998; 4: 534.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Patient as a Partner in Prescribing: Direct-to-Consumer Advertising, The. (Craig, Robert P.) 1998; 4: 15.
  • Pharmacy: Over- or Under-Regulated? (Ginsburg, Diane B., et al.) 1998; 4: 193.

    Reliability

  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.

    Reminder systems
    Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    Reporting
    Adverse Drug Events: A Plea for Reporting and New Rules to Ease the Burden. (Wanke, Lee A.) 1998; 4: 364.

    Research

  • Importance of Communication Skills for the Managed Care Pharmacist, The. (Desselle, Shane.) 1998; 4: 102.
  • International Movement of Japanese Pharmaceutical Industry: Reform of Japanese Health Policy, Part II. (Salmon, J. Warren, et al.) 1998; 4: 123.
  • International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.
  • Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.
  • Vital Role of Pharmacy Benefit Management Firms in Health Services Research, The. (Salmon, J. Warren, et al.) 1998; 4: 23.

    Research methodology

  • Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.
  • Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.
  • Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.

    Restrictions
    Comparison of Hypercholesterolemia Management in the Secondary Prevention of Coronary Heart Disease by Payor Types: Fee-For-Service, Medicare, and Managed Care Organizations. (Bramlet, Dean A., et al.) 1998; 4: 483.

    Review
    Use of Economic Models in Managed Care Pharmacy Decisions, The. (Summers, Kent H., et al.) 1998; 4: 42.

    Reward systems

  • Evolution of Pharmaceutical Care into Managed Care Environments, The. (Desselle, Shane, et al.) 1998; 4: 55.
  • Performance Reporting for Managed Care Prescription Programs. (Graden, Suzanne E., et al.) 1998; 4: 160.

    Riluzole
    Treatment of Patients with ALS: Implications for the Managed Care Pharmacist. (Barisano, Anthony, et al.) 1998; 4: 599.

    Risk assessment
    Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.

    SCRIPT

  • AMCP Joins "SCRIPT" Coalition to Investigate Medication Problems. 1998; 4: 607.
  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.

    Sampling
    Research Methodology: Designing a Research Study. (Schafermeyer, Kenneth W., et al.) 1998; 4: 504.

    Sankyo Co., Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Sensitivity analysis

  • Cost Benefit Analysis of Pharmaceutical Care in a Medicaid Population-From a Budgetary Perspective. (Lai, L. Leanne, et al.) 1998; 4: 303.
  • Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584. Service quality
  • Response-Oriented Patient Evaluation Survey (ROPES): An Administrator's Tool for Identifying Opportunities for Service Quality Improvement. (Kucukarslan, Suzan N., et al.) 1998; 4: 311.

    Sibutramine
    Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Significance
    Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.

    Specialty pharmacy
    Biotechnology as a Pharmacy Specialty. (Hargis, Jo Ellen.) 1998; 4: 465.

    Spotlight

  • Connecting Physicians to Pharmacies–and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35.
  • Mississippi Medicaid Waiver Breaks New Ground for Pharmacies. (Bloom, Marlene Z.) 1998; 4: 564.

    Standards

  • Connecting Physicians to Pharmacies-and Patients. (Bloom, Marlene Z.) 1998; 4: 473.
  • HCFA Proposes Standards for Electronic Transmission. 1998; 4: 436.
  • Information Requirements of Health Systems as Drug Purchasers: Does the FDA Have a Role in Setting Evidentiary Standards? (Langley, Paul C.) 1998; 4: 593.
  • Technology and Automation Update. (Felkey, Bill G., et al.) 1998; 4: 345.

    Statistics
    Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.

    Step therapy
    Innovative Drug Formulary Management Through Computer-Assisted Protocols. (Bailey, Michael, et al.) 1998; 4: 246.

    Stress management
    Burnout in a Sample of HMO Pharmacists Using the Maslach Burnout Inventory. (Gupchup, Gireesh V., et al.) 1998; 4: 495.

    T-Block
    A Predictive Cost Analysis Model for Estimating Formulary Impact of New Products in Managed Care. (Hedayati, Samuel, et al.) 1998; 4: 584.

    Takida Chemical Industry Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.

    Telepharmacy
    Electronic Prescribing: The Next Revolution in Pharmacy? (Sardinha, Carol.) 1998; 4: 35. The Plymouth Group

  • Local Area Market Dynamics. (Holubiak, Myron.) 1998; 4: 115.

    Therapeutic conversion
    Successful Disease Management Programs For Health And Welfare Fund Union Groups. (Zimmerman, Allan.) 1998; 4: 268.

    Therapeutic interchange

  • AMCP Issues Position Statement on Therapeutic Interchange. 1998; 4: 87.
  • Importance of Communication Skills for the Managed Care Pharmacist, The. (Desselle, Shane.) 1998; 4: 102.

    Trends

  • Trends. 1998; 4: 31, 235, 344, 435.

    Ulcer
    Defining Strategies for Peptic Ulcer Treatment: A Helicobacter pylori Economic Cost Model. (Kozma, Chris M., et al.) 1998; 4: 205.

    Unclaimed prescriptions
    A Study on the Characteristics of Prescription Transmittal Processes and the Effect of Patient Prescription Reminder System on Patient Compliance. (Hamilton, William R., et al.) 1998; 4: 174.

    United Kingdom
    Developing Disease State Management in the United Kingdom: An Obviously American Conjecture Finds Export Opportunities Abroad. (Lin, Swu-Jane.) 1998; 4: 275.

    Validity
    Research Methodology: Hypotheses, Measurement, Reliability, and Validity. (Motheral, Brenda R.) 1998; 4: 382.

    Variation
    Research Methodology: Some Statistical Considerations. (Hurd, Peter D.) 1998; 4: 617.

    Waxman-Hatch Act
    Maximizing Generic Substitution in Managed Care. (Keating, Edward J.) 1998; 4: 557.

    Weight loss

  • Cost-Effective Analysis of Appetite Suppressants for Obesity Treatment in a Managed Care Organization. (Weber, Mary P.) 1998; 4: 293.
  • Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies, The. (Anderson, Robert J., et al.) 1998; 4: 422.

    Xenical
    The Efficacy and Safety of Anorexiant Medication in the Treatment of Obesity: Implications for Managed Care Formularies. (Anderson, Robert J., et al.) 1998; 4: 422.

    Yamanouchi Pharmaceutical Co. Ltd.
    International Movement of Japan's Pharmaceutical Industry: Reform of Japanese Health Policies, Part III. (Chevalier, Kimiko, et al.) 1998; 4: 567.